Mumbai, Feb. 12 -- Clindamycin Phosphate Foam is a medication used to treat acne vulgaris in patients 12 years and older.
According to IQVIA sales data for the 12-month period ending December 2024, the Evoclin Foam, market achieved annual sales of approximately $5.8 million.
Glenmark Pharmaceuticals is a global innovation-driven pharmaceutical company with a presence across specialty, generics, and OTC businesses.
The drug maker had reported a consolidated net profit of Rs 354.21 crore in Q2 FY25 as against net loss of Rs 81.95 crore in Q2 FY24. Revenue from operations increased 7.59% year on year (YoY) to Rs 3,400.50 crore in the quarter ended 30 September 2024.
The scrip fell 2.82% to currently trade at Rs 1411.60 on the BSE.
Publi...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.